Xiaohui Liu
Principal investigator.
Biotech
Built from public records only: federal awards, patents, filings and papers.Is this you? Contact Noair Lab to claim this profile, correct it or hide it.
2018First federal award
$410KFederal grants as PI2 awards
1Patents grantedLatest Sep 20, 2022
0PapersOpenAlex
Federal awards and patents by year
AwardsPatents
2 awards · $410K
| Date | Agency | Award | Amount | Company |
|---|---|---|---|---|
| Apr 24, 2019 | NIH | SBIR Phase I Development of a novel class of selective HIF-2A inhibitors for kidney cancer | $55K | Kuda Therapeutics, Inc. |
| Jun 1, 2018 | NIH | SBIR Phase I Development of a novel class of selective HIF-2A inhibitors for kidney cancer | $355K | Kuda Therapeutics, Inc. |
2 patents as inventor
- US 11447482Kuda Therapeutics, Inc.Sep 20, 2022
- US Kuda Therapeutics, Inc.—
Matched by the first inventor’s name and the patent’s company.
Peer ranks
Federal funding#2,594
Awards as PI#1,252
Patents#155
Companies
- Kuda Therapeutics, Inc.Linked by awards · Biotech
Federal awards through Oct 21, 2026 and patents through Oct 20, 2026. Awards come from NIH, NSF and other agency records that name a principal investigator; DoD and NASA contract awards do not, so they are not shown here. Researchers are matched by name and company.